Chewable lozenge based on miconazole nitrate and associated manufacturing process

Abstract

The invention relates to a chewable lozenge containing Miconazole Nitrate, designed to replace an existing oral gel form: This lozenge is distinguished by its optimized formulation, which ensures microbiological stability, controlled release of the active substance and compliance with regulatory standards. Dosage, pharmacotechnical, microbiological, and antifungal efficacy controls confirmed the lozenge's compliance with the required specifications, demonstrating its efficacy and safety of use.